Abivax AAVXF
NASDAQ AAVXF
$139.00 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Abivax (AAVXF) Treasury Shares (2022 - 2025)

Abivax (AAVXF) posted Treasury Shares of -$2.1 million for Q4 2025, down 466.19% on a QoQ basis from -$362253.8 in Q4 2024, and down 466.19% year-over-year from $560104.1 in Q4 2024.

Analysis

Abivax (AAVXF) Treasury Shares (2022 - 2025) Analysis & Trends

Abivax has reported Treasury Shares for 4 years, with the latest figure at -$2.1 million in Q4 2025.

  • On a quarterly basis, Treasury Shares fell 466.19% year-over-year to -$2.1 million in Q4 2025; TTM through Dec 2025 was -$2.1 million, a 466.19% decrease from a year earlier, with the FY2025 full-year figure at -$2.1 million, down 466.19% from the prior year.
  • Treasury Shares was -$2.1 million for Q4 2025 at Abivax, down from -$362253.8 in the prior quarter.
  • The five-year high for Treasury Shares was $463.8 million in Q4 2024, with the low at -$36.6 million in Q4 2023.
  • Average Treasury Shares over 4 years is -$1.2 million, with a median of -$1.1 million recorded in 2023.
  • The sharpest annual moves came in 2024 and 2025: Treasury Shares surged 80.89% in 2024, then slumped 466.19% in 2025.
  • Over 4 years, Treasury Shares stood at -$345863.9 in 2022, then sank by 448.14% to -$1.9 million in 2023, then soared by 80.89% to -$362253.8 in 2024, then plunged by 466.19% to -$2.1 million in 2025.
  • The last three Treasury Shares figures came in at -$2.1 million (Q4 2025), -$362253.8 (Q4 2024), and -$1.9 million (Q4 2023), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Amgen 211.37 Bn 197.38 Bn 7.24 Bn -
2 Gilead Sciences 181.12 Bn 177.94 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 132.11 Bn 124.26 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 82.51 Bn 74.52 Bn 3.93 Bn 36.40 Mn
5 Argenx Se 61.69 Bn 56.50 Bn 1.37 Bn -
6 Moderna 54.62 Bn 49.48 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 34.14 Bn 30.84 Bn 992.69 Mn -
8 Biogen 31.29 Bn 30.01 Bn 1.96 Bn -23.80 Mn
9 Roivant Sciences 30.09 Bn 30.09 Bn 1.16 Mn -
10 Abivax 10.92 Bn 10.92 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -2.05 Mn
Dec 31, 2025 -2.05 Mn
Dec 31, 2024 -362,253.84
Dec 31, 2024 463.77 Mn
Dec 31, 2024 -362,253.84
Dec 31, 2024 463.77 Mn
Sep 30, 2024 131,786.34
Sep 30, 2024 131,786.34
Jun 30, 2024 -41,998.62
Jun 30, 2024 -41,998.62
Mar 31, 2024 -6,518.17
Mar 31, 2024 -6,518.17
Dec 31, 2023 -1.90 Mn
Dec 31, 2023 -36.58 Mn
Dec 31, 2023 -1.90 Mn
Dec 31, 2023 -36.58 Mn
Dec 31, 2022 -345,863.86
Dec 31, 2022 -345,863.86